Celgene diversifies portfolio with purchase of Juno Therapeutics By: New York Business Journal via Business Journals January 22, 2018 at 10:10 AM EST Earlier this month, Celgene announced that it was taking over Impact Biomedicines in a $7 billion transaction. Read More >>